RESEARCH TRIANGLE PARK, N.C. & CAMBRIDGE, United Kingdom--(BUSINESS WIRE)--Quintiles, the world’s leading biopharmaceutical services company, and Population Genetics Technologies Ltd. (PGT), creator of innovative solutions to reduce the costs and complexity of large-scale genomic testing and enable correlations with clinical outcomes, today announced a commercial collaboration to bring genomic testing into mainstream drug development in order to produce safer, more effective medicines.
